Sentinel lymph node biopsy rates in Victoria, 2018 and 2019.

Autor: Watts, Caroline, Spillane, Andrew, Henderson, Michael A, Cust, Anne, Braithwaite, J, Gyorki, DE, Hong, AM, Kelly, JW, Long, GV, Mar, VJ, Menzies, AM, Morton, RL, Rapport, F, Saw, RPM, Schmid, H, Scolyer, RA, Smith, AL, Winder, A, Mann, GJ
Zdroj: Medical Journal of Australia; Aug2022, Vol. 217 Issue 4, p208-209, 2p
Abstrakt: Keywords: Melanoma; Surgical oncology EN Melanoma Surgical oncology 208 209 2 08/17/22 20220815 NES 220815 Sentinel lymph node biopsy (SLNB) is a staging procedure for assessing metastatic spread from a primary melanoma to the draining lymph nodes. During 2018 and 2019, 892 of 1855 people diagnosed with invasive melanomas of greater than 1.0 mm thickness (48%) and 151 of 597 with melanomas of 0.8-1.0 mm thickness (25%) underwent SLNB. [Extracted from the article]
Databáze: Supplemental Index